SUNPHARMA — Sun Pharmaceutical Industries Share News
0.000.00%
- IN₹4.51tn
- IN₹4.19tn
- IN₹584.62bn
India's Sun Pharma posts higher quarterly profit on strong demand
Brief: Sun Pharma Q1 Consol Net Pat 28.95 Billion Rupees
Preview: India's Sun Pharmaceutical inches higher ahead of Q1 results
India's Sun Pharma hits record high after Brazil's approval for semaglutide
Brief: Sun Pharma Says Receives ANVISA Approval To Manufacture And Market Semaglutide In Brazil
Brief: Sun Pharma Says Philogen Resubmits Marketing Authorization Application To EMA For Nidlegy In Melanoma
India's pharma stocks fall after Trump outlines steep tariffs on generic drug imports
India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports
South Africa regulator reviews 12 generic semaglutide applications
India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease
India's Sun Pharma wins South Africa approval to launch generic Ozempic
Brief: Sun Pharma Receives Sahpra Approval To Manufacture And Market Generic Semaglutide In South Africa
Sun Pharma to acquire Innovcare Lifesciences for $28.7 million
Brief: Sun Pharma Says To Buy 100% Of Innovcare Lifesciences
Organon wins US approval to widen use of arthritis biosimilar drug
Media: State Bank of India plans $1 billion funding for Sun Pharma's US Deal - Bloomberg News
Brief: Sun Pharma To Present Long-Term Follow-Up Data On Unloxcyt
Street View: Sun Pharma steady on specialty demand, but near-term growth seen slowing
India's top drugmaker Sun Pharma beats profit view on specialty drugs demand (updated)